Understanding both the transcriptional and post-transcriptional mechanisms that control PARP7 levels may have clinical relevance given the recent data suggesting PARP7 may impact patient survival for breast and ovarian cancer [23,25]. This evidence concerns the gene TIPARP and ovarian cancer.